Management of metastatic castration-resistant prostate cancer in Middle East African countries: Challenges and strategic recommendations.

Bazarbashi, Shouki; Alsharm, Abdullah; Meshref, Alaa; Mrabti, Hind; Ansari, Jawaher; Ghosn, Marwan; Abdulla, Mohamed; Urun, Yuksel

Bazarbashi, Shouki; Alsharm, Abdullah; Meshref, Alaa; Mrabti, Hind; Ansari, Jawaher; Ghosn, Marwan; Abdulla, Mohamed; Urun, Yuksel.

Afiliación

Bazarbashi S; Oncology Center, King Faisal Specialist Hospital and Research Centre, King Fahad Medical City, Riyadh, Saudi Arabia.
Alsharm A; Comprehensive Cancer Center, King Fahad Medical City, King Fahad Medical City, Riyadh, Saudi Arabia.
Meshref A; Department of Urology, Cairo University, Egypt.
Mrabti H; Department of Medical Oncology, National Institute of Oncology, Mohamed V University-Rabat, Morocco.
Ansari J; Department of Medical Oncology, Tawam Hospital, Al Ain, UAE.
Ghosn M; Department of Medical Oncology, Saint Joseph University in Beirut, Lebanon.
Abdulla M; Department of Clinical Oncology, Cairo University, Egypt.
Urun Y; Department of Medical Oncology, Ankara University, Turkey.

Urol Ann ; 14(4): 303-313, 2022.

Article en En | MEDLINE | ID: mdl-36505997

Palabras clave

Genetic testing; Middle East African region; metastatic castration-resistant prostate cancer; multidisciplinary care

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: Urol Ann Año: 2022 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google